Materials And Products Tenders

Medicines with the Active Ingredient Teriparatide (Atc: H05aa02)

Medicines with the Active Ingredient Fluorouracil (Atc: D11af05)

Medicines with the Active Ingredient Ebastine (Atc: R06ax22)

Medicines with the Active Ingredient Bempedoic Acid (Atc: C10ax15)

AZVOE - Renovation Of The AFF Sewage Treatment Plant In Lautlingen - Planner Selection Process For Civil Structures DRESO_INFRA-2023-0024

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V (Open House Model)

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Rotigotine (N04bc09) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Fondaparinux (B01ax05) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Sarilumab (L04ac14) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Everolimus (L04aa18) as Part of a So-Called Open House Model.